Last date for submission of paper: unknown; Contact person: Emily Hawkings; Discover novel case studies on the latest challenges and innovations in inhaled therapy formulation and device development, with in-depth presentations focusing on alternative therapeutic areas and advancements in combination productsOver 150 delegates from the inhalation, formulation and drug delivery industry representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic & research institutions.Over 20 presentations and case studies focusing on the emerging therapies and key issues in inhalation and respiratory drug delivery as well as the latest developments in medical devices and digital health products.View Agenda: https://bit.ly/35dZ8hcCo-located with the 6th Annual Formulation & Drug Delivery Congress and Biomanufacturing Congress.For more information contact [email protected] or visit the website: https://bit.ly/2KFgtrvGo Social: Join our Formulation & Drug Delivery Network on LinkedIn, follow us on Twitter @FDDCongress & join the conversation at #FDDUK20*2020 Live Webinar*Inhaled Targeted-Inhibition Of Galectin-3 Dose Dependently Blocks Plasma Biomarkers In Patients With Idiopathic Pulmonary FibrosTue, Mar 3, 2020 2:00 PM - 3:00 PM GMTPresented by Tariq Sethi, Co-Founder, Galacto Biotech and Former Chief Scientist Vice President Clinical Development Unit, AstraZenecaRegister (free): https://bit.ly/37NpwAv